This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Agency for Science, Technology and Research. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2023
Title: Hwei-In Shawn Lim: Innovator in Stem Cell Research
Introduction
Hwei-In Shawn Lim is a prominent inventor based in Singapore, known for his significant contributions to the field of stem cell research. With a focus on differentiating pluripotent cells into specialized cell types, his work has the potential to advance therapeutic applications in regenerative medicine. He holds 2 patents that showcase his innovative methodologies.
Latest Patents
Hwei-In Shawn Lim's latest patents include groundbreaking methods for differentiating pluripotent stem cells into microglial cells and primitive-like macrophages. The first patent, titled "Differentiation of pluripotent cells into microglial cells expressing IBA-1," describes a method of culturing primitive macrophages from stem cells. This method involves incubating stem cells with a serum-free culture media containing a GSK3 inhibitor, followed by further differentiation steps to achieve the desired cell types. The second patent, "Method of differentiating human pluripotent stem cells into primitive macrophages," outlines a similar approach, emphasizing the use of specific culture media to drive the differentiation process. Both patents highlight the potential applications of these primitive-like macrophages in in-vitro disease models and therapeutic screenings.
Career Highlights
Hwei-In Shawn Lim is affiliated with the Agency for Science, Technology and Research, where he continues to push the boundaries of stem cell research. His innovative techniques have garnered attention in the scientific community, contributing to advancements in understanding cell differentiation and its implications for medical therapies.
Collaborations
Throughout his career, Hwei-In has collaborated with notable colleagues, including Tara Huber and Florent Ginhoux. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the field.
Conclusion
Hwei-In Shawn Lim's contributions to stem cell research through his innovative patents and collaborative efforts position him as a key figure in advancing medical science. His work not only enhances our understanding of cell differentiation but also opens new avenues for therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile